on 21 May 2019
Last Applicant/ Owned by
Avenida Paseo de las Palmas No. 340
Ciudad de MĂ©xico
MX
11000
Serial Number
75176361 filed on 03rd Oct 1996
Registration Number
2241440 registered on 27th Apr 1999
Filing Basis
1. intent to use
Disclaimer
NO DATA
pharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspension, medicated syrup and ointment, all for treatment as a cough suppressant, and expectorant, [ activity against anaerobic bacteria, Trichomona vaginalis, Entamoeba histolytica, and giardia lamblia, ] as an antifungal agent for treatment of Oropharyngeal and esophageal candidiasis, [ can Read More
pharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspension, medicated syrup and ointment, all for treatment as a cough suppressant, and expectorant, [ activity against anaerobic bacteria, Trichomona vaginalis, Entamoeba histolytica, and giardia lamblia, ] as an antifungal agent for treatment of Oropharyngeal and esophageal candidiasis, [ candidial urinary tract infections, peritonitis and systemic candidal infections, candidemia, disseminated candidiasis and pneumonia, cryptococcal meningitis, candidal genital tract infections, ] as an analgesis anti-inflamatory non steroidal inhibitor of prostaglandin synthetase, [ analgesic and minor tranquilizer, active immunization against tetanus, peripheral neuritis, neuralgias, peripheral neuritis, neuralgias and haematopoietic, antifungal agent for treatment of systemic blastomycosis, histoplasmosis paracoccidloidomycosis, fungal infection of the gastrointestinal tract and tinea infections of the skin, and nails, sulphonylurea and biguanide, hipoglycaemic agent, activity against trichomonas vaginalis, entamoeba histolytica and Giardia lamblia, anaerobic bacteria, ] histamine H1-receptor antagonist and prophylactic treatment of asthma, and treatment of allergic conditions such as rhinitis and conjuntivitis,[ analgesic, ] anti-inflamatory non steroidal, for inhibiting prostaglanding synthetase, [ analgesic, anti-inflammatory non steroidal, inhibitor of prostaglandin synthetase ] and muscle relaxant, analgesic, antipyretic, [ sulphonylurea hipoglycaemic agent, for inhibiting as an angiotensin-converting enzyme, treatment of congestive heart failure and asymptomatic left ventricular dysfunction, diuretic treatment of congestive heart failure, hypertension, cardiac, renal hepatogenic oedema, peripheral neuritis, neuralgias and analgesic, ] a broad spectrum antibiotic, effective against a wide range of Gram positive and Gram negative aerobic and anaerobic bacterias, [ histamin H2-receptor antagonist in the treatment of gastric an duodenal ulcer, Zollinger-Ellison syndrome, iron deficiency and anemia for children or adults, ] anixolytic, anticonvulsant, sedative, muscle relaxant, [ histamine H2-receptor antagonist in the treatment of gastric and duodenal ulcer Zollinger-Ellison syndrome, ] multivitamin treatment and prevention of vitamin B1-B6-B12 deficiency, [ tricyclic antidepressant, treatment of nocturnal enuresis in children, inhibits angiotensin-converting enzyme, ] treatment of hypertension and congestive heart failure, treatment and prevention of vitamic C deficiency, treatment and prevention of seborrhoea and dandruff, analgesic no narcotic
No 75176361
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
16th Jan 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
16th Jan 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
21st May 2019 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
21st May 2019 | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) |
21st May 2019 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
20th May 2019 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
16th Apr 2019 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
16th Apr 2019 | TEAS SECTION 8 & 9 RECEIVED |
27th Apr 2018 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
26th Feb 2009 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |